European cancer organisation essential requirements for quality cancer care (ERQCC): lung cancer

T Berghmans, Y Lievens, M Aapro, AM Baird… - Lung Cancer, 2020 - Elsevier
Abstract European Cancer Organisation Essential Requirements for Quality Cancer Care
(ERQCC) are written by experts representing all disciplines involved in cancer care in …

[HTML][HTML] Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

F Martucci, M Pascale, MC Valli, GA Pesce… - Frontiers in …, 2020 - frontiersin.org
Background: Molecular imaging methods are currently used in the management of patients
with lung cancer. Compared to non-small cell lung cancer, less data are available about the …

Silencing circPVT1 enhances radiosensitivity in non-small cell lung cancer by sponging microRNA-1208

M Huang, T Li, Q Wang, C Li, H Zhou… - Cancer …, 2021 - content.iospress.com
BACKGROUND: Radiotherapy is one of main useful therapies in non-small cell lung cancer
(NSCLC). Nevertheless, the underlying mechanism between NSCLC cell radiosensitivity …

Comparison of diagnostic accuracy for TNM stage among whole-body MRI and coregistered PET/MRI using 1.5-T and 3-T MRI systems and integrated PET/CT for non …

Y Ohno, Y Takeshi, D Takenaka… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to compare diagnostic accuracy of TNM stage for
whole-body MRI and coregistered PET/MRI using 1.5-T and 3-T MRI systems and PET/CT in …

Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer

JB Chen, XF Kong, F Mu, TY Lu, YY Lu… - Medical Gas …, 2020 - journals.lww.com
Chemotherapy, targeted therapy, and immunotherapy are used against advanced non-small
cell lung cancer. A clinically efficacious method for relieving the adverse events associated …

Small cell lung cancer staging: prospective comparison of conventional staging tests, FDG PET/CT, whole-body MRI, and coregistered FDG PET/MRI

Y Ohno, T Yoshikawa, D Takenaka… - American Journal of …, 2022 - Am Roentgen Ray Soc
Please see the Editorial Comment by Paige Bennett discussing this article. Please see the
Author Video associated with this article. BACKGROUND. Whole-body MRI and FDG …

Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self …

JB Chen, XF Kong, W Qian, F Mu, TY Lu… - Medical Gas …, 2020 - journals.lww.com
Following standard treatments, the traditional model for enhancing anti-tumor immunity
involves performing immune reconstitution (eg, adoptive immune cell therapies or …

Ethnic disparities in imaging utilization at diagnosis of non-small cell lung cancer

RL Morgan, SD Karam… - JNCI: Journal of the …, 2020 - academic.oup.com
Background Prior research demonstrated statistically significant racial disparities related to
lung cancer treatment and outcomes. We examined differences in initial imaging and …

CircVAPA exerts oncogenic property in non‐small cell lung cancer by the miR‐876‐5p/WNT5A axis

Y Zhao, Q Dai, X Fu, Q Chen, Y Tang… - The Journal of Gene …, 2021 - Wiley Online Library
Background Non‐small cell lung cancer (NSCLC) is one of the most fatal malignant tumors.
Emerging studies have clarified the crucial roles of circular RNAs (circRNAs) in the …

Imaging Recommendations for Diagnosis, Staging, and Management of Lung Cancer

A Irodi, AS Bhalla, LR Vimala, T Yadav… - Indian Journal of …, 2023 - thieme-connect.com
Globally and in India, lung cancer is one of the leading malignancies in terms of incidence
and mortality. Smoking and environmental pollution are the common risk factors for …